Daewoong on solid growth track

Daewoong Pharmaceutical, one of the country’s leading pharmaceutical companies, said Thursday it has returned to making profit in the first half of this year from a year earlier, buoyed by brisk sales of flagship products.

The four major brands posted 54.6 billion won in sales in the second half of this year; Olmetec (11.7 billion won), Gliatilin (16.6 billion won), Albis (14.6 billion won) ...